Zhang, Minghui <br/><br/>
Application of chimeric antigen receptor-engineered T cells in ovarian cancer therapy.  [electronic resource] 

 -  Immunotherapy  09 2017 
 - 851-861 p.  digital 
<br/><br/> Publication Type: Journal Article; Review 
<br/><br/><label>ISSN: </label>1750-7448 
<br/><br/><label>Standard No.: </label>10.2217/imt-2017-0039  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Animals<br/>Cancer Vaccines--immunology<br/>Female<br/>Genetic Therapy<br/>Humans<br/>Immunotherapy, Adoptive--methods<br/>Ovarian Neoplasms--immunology<br/>Receptors, Antigen, T-Cell--genetics<br/>Recombinant Fusion Proteins--genetics<br/>Signal Transduction<br/>T-Lymphocytes--physiology<br/>Translational Research, Biomedical